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Abstract 
 
Background: Endolymphatic sac surgery is an invasive procedure recommended to patients with 
Menière’s disease.  
Aims/Objectives: To provide an overview and quality assessment of the existing evidence and to 
provide an updated assessment of the utility of endolymphatic sac surgery in Menière’s disease. 
Material and Methods: We performed a systematic literature search for systematic reviews and 
randomized controlled trials (RCTs). The AMSTAR tool was used to assess the quality of 
systematic reviews and the Cochrane risk of bias tool for RCTs. The overall certainty of effects for 
the individual outcomes was evaluated using the GRADE approach. 
Results: One systematic review of high quality matched the inclusion criteria, and included three 
RCTs. An updated literature search from the last search date of the included review provided no 
further relevant RCTs. The identified RCTs individually reported a positive effect of both the 
placebo and active treatment groups following surgery, strongly indicative of a placebo effect. The 
overall certainty of the effect very low.  
Conclusions and Significance: There is still a lack of high quality research suggesting that 





Menière’s disease is characterized by spontaneous episodes of vertigo combined with tinnitus, aural 2 
fullness and fluctuating low frequency sensorineural hearing loss. It is a chronic inner ear disease 3 
where both hearing loss and vestibular deficits generally progress regardless of treatment. Even 4 
though the disease was first described more than 150 years ago, the etiology remains uncertain [1]. 5 
Endolymphatic hydrops due to endolymphatic malabsorption in the labyrinth’s endolymphatic sac 6 
is considered a hallmark of Menière’s disease [1]. Within recent years it has become possible to 7 
visualize endolymphatic hydrops with gadolinium magnetic resonance imaging (MRI). However, 8 
this has not been globally implemented and it is not a requirement in the newest set of diagnostic 9 
criteria from the Barany society [2]. As of now, there is no cure for Menière’s disease. Wide ranges 10 
of different treatment modalities exist including dietary salt restriction as well as treatment with 11 
diuretics in an attempt to influence the endolymphatic pressure imbalance. Severely disabled 12 
patients with Menière disease, who have failed to respond to other available treatment modalities, 13 
may be offered endolymphatic sac surgery. Endolymphatic sac surgery is performed using different 14 
surgical procedures such as endolymphatic sac decompression and duct blockage. Both methods 15 
tend to regulate the endolymphatic flow using different approaches. 16 
Endolymphatic sac surgery is an invasive procedure and therefore high-quality evidence is essential 17 
to evaluate its potential positive effects and associated risks, especially in relation to hearing loss. 18 
The objective of this review was to provide an overview and quality assessment of the existing 19 
evidence and, based on the identified literature, to provide an update on the usage of endolymphatic 20 
sac surgery in Menière’s disease. The primary focus of this particular systematic review was 21 
patients (≥18 years of age) diagnosed with either definite or probable Meniére’s disease undergoing 22 
endolymphatic sac surgery compared to no surgery/placebo surgery. Specifically, we sought to 23 
evaluate the effects of this treatment in regards to frequency, duration and severity of vertiginous 24 
attacks, serious adverse events as well as quality of life, impact on daily life, tinnitus, patient 25 
reported operative effect, and hearing loss. 26 
 27 
Methods 28 
This work was performed in accordance with the guidelines of the Cochrane Collaboration and 29 
Preferred Reporting Items for Systematic review and Meta-analysis Protocols (PRISMA) [3,4]. The 30 
protocol is registered in PROSPERO. Registration number: CRD42018110118.  31 
This review was a part of a larger guideline on Menière’s disease which was published by the 32 
Danish Health Authorities in 2018. 33 
 34 
Literature search 35 
We performed a systematic literature search in two steps. Initially, we identified systematic reviews 36 
that, in accordance to our inclusion criteria, investigated the use of endolymphatic sac surgery in 37 
Menière’s disease. The search for systematic reviews was performed on December 19th, 2017, with 38 
no restrictions regarding date of publication. Subsequently, we performed a search to identify 39 
individual randomized controlled trials (RCTs). The search for RCTs was performed February 2nd 40 
2018, and was limited to the publication dates of the latest search in the identified systematic 41 
reviews (which in this case was November 2012). The search for individual RCTs was limited to 42 
the search date of the Cochrane review, as the search strategy and inclusion criteria of the Cochrane 43 
review was identical to that of the current manuscript. As such, the thorough and well-performed 44 
literature search performed in the Cochrane review served as a foundation, from which the authors 45 
of the current review performed an updated literature search All searches were performed in the 46 
databases EMBASE, MEDLINE, and PsycINFO via Ovid (Wolters Kluver, Aalphen aan der Rijn, 47 
the Netherands). The search strategy was developed using medical subject heading terms (MeSH) 48 
and text words related to our eligibility criteria, i.e. Meniere, Menieres, Meniere disease/syndrome 49 
(English), Menieres sygdom/syndrome (Danish), menieres sykdom (Norwegian), Menieres sjukdom 50 
(Swedish). There were no restrictions in regard to publication status, however, the search was 51 
limited to literature written in English, Danish, Norwegian and Swedish. Search protocols are 52 
provided in the supplementary material section. 53 
 54 
Study selection: 55 
The results of the search for systematic reviews and individual RCTs were imported to RefWorks 56 
(Proquest, Ann Arbor Michigan, USA). Subsequently, duplicate references were removed and the 57 
remaining records were imported into Covidence software (Covidence, Melbourne Australia) for 58 
literature screening and data management. Titles and abstracts of potential studies was screened by 59 
one reviewer (LD) to assess if the inclusion criteria were met. The initial selection of studies was 60 
assessed by an additional reviewer (HEC). Subsequently, the full text of potential studies was 61 
screened independently by two review authors (LD and JHS) for eligibility. Disagreement was 62 
resolved through discussion or by consultation of a third reviewer (HEC). Neither of the review 63 
authors were blinded in regard to journal titles, study authors/institutions or year of publication. A 64 
PRISMA flow chart [5] was created and used to document the number of studies identified. 65 
The selection of studies was based on the Population, Intervention, Comparison and Outcome 66 
(PICO) framework [6] with the following structure: Population: Inclusion criteria were age 18 or 67 
above, and a diagnosis of definite or probably Menière's disease as defined by Bárány Society 2015 68 
[2] or the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) criteria 69 
from 1995 [7].  Bárány Society diagnostic criteria for definite Menière's disease include: A) Two or 70 
more spontaneous episodes with dizziness, each lasting between 20 minutes and 12 hours. B) At 71 
least one hearing test showing low to medium frequency sensorineural hearing loss on the affected 72 
ear before, during or after a dizziness episode. C) Fluctuating symptoms of the affected ear in the 73 
form of tinnitus, hearing loss or increased volume / pressure. D) Symptoms cannot be explained 74 
better by another diagnosis. Partially, the diagnostic criteria for probable Menière's disease include 75 
the same criteria (A, C, D), but no evidence of a continuing or fluctuating sensorineural hearing loss 76 
is required. Exclusion criteria were patients with a diagnosis of vertigo other than Menière's disease 77 
and patients with Ménière’s syndrome that did not fulfill the appropriate criteria as described above. 78 
Intervention and Comparison: We included randomized controlled studies investigating the usage 79 
of endolymphatic sac surgery compared to patients that did not receive endolymphatic sac surgery. 80 
Outcome: The primary outcomes included the frequency of vertigo attack(s) and serious adverse 81 
events as assessed at a minimum of three month following initial treatment. Secondary outcomes 82 
included; hearing loss, reduction of tinnitus, quality of life, impact on daily life, vestibular function, 83 
frequency and length of vertiginous attacks, severity of the attacks and patient-reported operative 84 
effect. Tinnitus and duration of the vertiginous attacks were investigated three months after 85 
initiating of the intervention. The remaining secondary outcomes were evaluated at the longest 86 
follow-up (minimum one year after the intervention). Frequency and duration of vertiginous attacks 87 
at longest follow-up (minimum one year after the intervention) were included as a secondary 88 
outcome measure.  89 
 90 
Quality assessment and data extraction 91 
The quality of the included systematic review was assessed using the AMSTAR tool [8]. The 92 
AMSTAR evaluation was performed to ensure methodological rigidity of the review, from which 93 
the second literature search for individual RCTs was based upon. The quality of individual RCTs 94 
was evaluated using the Cochrane risk of bias tool which included the following characteristics: 95 
Randomization sequence generation; Treatment allocation concealment; Blinding of patients and 96 
personnel; Blinding of outcome assessors; Completeness of outcome data; Selective outcome 97 
reporting; Other sources of bias. Following a combined assessment of the results reported in the 98 
included studies, the certainty of effect on the individual outcomes was evaluated using the GRADE 99 
approach [9]. Results from RCT studies are by default considered to be of high quality, yet the 100 
quality may be downgraded to either moderate, low or very low based upon the following domains: 101 
overall risk of bias; inconsistency; indirectness; imprecision and publication bias. The overall 102 
quality of evidence was subsequently based upon the lowest quality of the primary outcome in 103 
accordance to the GRADE approach.  104 
 105 
Two review authors (LD and HEC) independently performed the quality assessment and subsequent 106 
data extraction. Data extraction included population demographics, baseline characteristics, details 107 
on intervention and control conditions, study design, outcome, and time of measurement. 108 
All data was exported to Review Manager (version 5.2) (Informer Technologies Inc) and any 109 
potential discrepancies were resolved through discussion. 110 
 111 
Statistical analysis  112 
Due to a heterogenic reporting style and inconsistent reporting of primary data in the identified 113 
studies, it was not possible to perform any data-analysis or summary of findings. As such, the effect 114 
estimates for the individual outcome and overall quality of the evidence were solely narratively 115 
described. Authors of the included studies were not contacted for further information. 116 
 117 
  118 
Results  119 
In the search for systematic reviews, we identified 87 references. Following removal of duplicates 120 
and none-relevant references, we identified seven systematic reviews [10-16] that we obtained in 121 
full text and read thoroughly. Of these, one systematic Cochrane review [15], which included three 122 
relevant RCTs, matched our clinical question,.  A search for further RCTs based on the search date 123 
from the Cochrane review (which was November 2012) [15] identified 57 references. Following the 124 
screening and selection process, there were no RCTs published after the search date from the 125 
Cochrane review, that matched the inclusion criteria. The total amount of evidence in this review is 126 
based on three RCT with a total of number of 59 patients [17-19]. A flowchart can be seen in figure 127 
1. 128 
 129 
The included studies: 130 
The populations in the included studies were described as classical Menière’s disease patients 131 
without specification of the diagnostic criteria applied. Thomsen et al., (1981) [19] compared 132 
endolymphatic shunt surgery with mastoidectomy in 30 patients refractory to medical treatment. All 133 
patients filled out a dizziness related questionnaire (frequency, duration, and severity of attacks) as 134 
well as a registration of their self-perceived symptoms of vertigo, tinnitus, and hearing impairment 135 
on a scale ranging from zero to three (higher scores indicative of more severe symptoms). These 136 
measurements were performed three months prior to and 12 months following surgery. At the end 137 
of the trial, patients were asked about their subjective evaluation of the effect and a pure tone 138 
audiometry (PTA) was performed. The study by Bretlau et al., (1989) [17] consisted of a nine-year 139 
follow-up of the study by Thomsen et al., (1981) [19] In this follow-up study, 23 patients from 140 
Thomsen et al., (1981) [19] participated. Patients were once again asked about their subjective 141 
evaluation of the surgical effect and a PTA was performed. The study from Thomsen et al., (1998) 142 
[18] compared endolymphatic shunt surgery with insertion of ventilation tubes in 29 patients 143 
refractory to medical treatment. On a daily basis, the patients registered frequency and severity of 144 
vertiginous attacks six months pre-surgery and 12 months following surgery. Patients were 145 
interviewed about their subjective symptoms and a PTA audiogram was performed.  146 
 147 
Frequency of vertigo attacks  148 
In the study by Thomsen et al., (1998) [18]  there was a general improvement in patient-reported 149 
vertigo scores following surgery both in the active group and in the control group when compared 150 
to preoperative conditions (p<0.01, no primary data provided). When treatment groups were 151 
compared, patients in the placebo group had a slightly worse vertigo score following surgery 152 
compared to the active group (p<0.05, no primary data provided). In the nine-year follow-up by 153 
Bretlau et at., (1989) [17] only one patient in the active group continued to have periodic attacks, 154 
whereas no patients in the placebo group had any recurrent attacks. There continued to be no 155 
difference between the two treatment groups (no data or statistical analysis provided). In another 156 
study by Thomsen et al., (1998) [17], there was a reduction in the number of dizzy spells in both 157 
groups following endolymphatic shunt surgery and insertion of ventilation tube, with approximately 158 
30 percent of patients in both groups having no attacks following surgery. There were no significant 159 
differences between the two treatment groups (no primary data provided).  160 
 161 
Reduction in tinnitus  162 
In the study by Thomsen et al., (1981) [19], an improvement in patient-reported tinnitus was 163 
observed in the active group following surgery when comparing to preoperative conditions. There 164 
was no difference between the active group and the placebo group (no primary data or statistical 165 
analysis provided). In Thomsen et al., (1998) [17], there was no significant effect on tinnitus in 166 
neither the placebo group nor the shunt surgery group (no primary data provided, p>0.05).  167 
 168 
Impact on daily life 169 
Following surgery, in terms of functionality, Thomsen et al., (1981) [19] reported a significant 170 
reduction in disease severity in both groups when assessed by investigators’ global score (no 171 
primary data provided, p<0.005). There was, however, no differences in disease severity between 172 
the placebo group and the active groups (no primary data or statistical analysis provided). In 173 
correlation, Thomsen et al. 1998 [18] reported an improved level of functionality in both groups 174 
following surgery (no primary data provided, p<0.05), with no difference between the two groups 175 
(no primary data provided).   176 
 177 
Hearing loss  178 
At the end of the trial, Thomsen et al., (1981) [19] found no significant differences between the 179 
placebo group and the active group in regard to average mean values of 250, 500 and 1000 Hz, as 180 
measured by pure tone audiometry (PTA) (no primary data or statistical analysis provided). In the 181 
nine-year follow-up from Bretlau et al. (1989) [17],  there continued to be non-significant inter-182 
group difference between mean values measured by PTA (no primary data or statistical analysis 183 
provided). In the study by Thomsen et al., (1998) [18], there was no significant differences in PTA 184 
between groups, neither before surgery (sac shunt: 55dB (23-86); ventilation tube: 54db (8-71), 185 
median (range)) nor 12 months following surgery (sac shunt: 55 (26-anacusis); ventilation tube 48 186 
(5-79), median range) (p>0.05). 187 
 188 
Patient-reported operative effect  189 
In Thomsen et al. (1981) [19], both groups reported positive operative effect as compared to pre-190 
surgery (73% active group; 67% placebo group), with no significant differences between the two 191 
groups (no analysis provided). In the nine-year follow-up study by Bretlau et al., (1989), 70 % of 192 
the patients in both groups continued to consider their surgery successful (no analysis provided). In 193 
Thomsen et al., (1998), 86% of patients receiving ventilation tube and 60% receiving 194 
endolymphatic shunt surgery, reported a favorable effect of the intervention. There were no 195 
significant differences between the two groups (p>0.05).  196 
 197 
None of the studies reported on serious adverse events, quality of life, length of vertigo attack or 198 
vestibular function. 199 
 200 
Quality of evidence  201 
The AMSTAR evaluation of the included systematic review showed that this review had an 202 
adequate description of all necessary domains, and thus was considered of high quality. 203 
The assessment of the individual RCTs by the Cochrane Risk of bias tool, showed that in all three 204 
studies the random sequence generation and allocation concealment was unclear and there was a 205 
high risk of other biases due to inadequate reporting of primary data and statistical analysis. 206 
Subsequent rating of the overall certainty of effect was very low for all outcomes due to serious 207 
imprecision and serious risk of bias. An overview of the AMSTAR evaluation and the Cochrane 208 
risk of bias can be found in the figures 2 and 3. 209 
 210 
Discussion  211 
The objective was to provide an overview and quality assessment of the current evidence regarding 212 
the use of endolymphatic sac surgery in patients with definite and probable Menière’s disease. Our 213 
findings showed that, despite surgery being applied to treat Meniere disease since 1927, the amount 214 
of well-performed RCTs on the matter continues to be scarce. Of the identified literature, only three 215 
RCTs were found compatible with the inclusion criteria of this particular review. All studies 216 
investigated the use of endolymphatic sac surgery, but one of the RCT studies was a nine-year 217 
follow-up on the patients from one of the other RCTs.  The included RCTs were identified in one 218 
high quality Cochrane review as assessed by the AMSTAR tool. An updated literature search 219 
showed that no further relevant RCTs have been published since the search applied in the 220 
systematic review. As assessed by the Cochrane risk of bias tool, the quality of the included RCTs 221 
was poor, with inadequate reporting of primary data and underlying statistical analysis, in addition 222 
to the inclusion of few patients and other substantial methodological flaws. In accordance, the 223 
overall certainty of the effect on the predefined outcomes, as assessed by the GRADE approach, 224 
was very low. Due to a severe lack in the reporting of primary data in all three studies, it was not 225 
possible to perform any combined analysis and thus to identify any common effects of this 226 
intervention. All three studies, however, individually reported of an improvement in symptoms in 227 
both groups after surgery when compared with preoperative conditions. This included an 228 
improvement in vertigo, impact on daily life and in patient-reported operative effect. When the 229 
placebo and active groups were compared, there were no significant differences in treatment effects 230 
for these above-mentioned outcomes. In accordance to the findings within the included studies, 231 
these findings may indicate a substantial placebo effect following surgery for Menière’s disease, yet 232 
it may also to some extend reflect the natural disease progression found in Menières disease.  233 
It is important to include a suspected non-effective placebo treatment in studies on surgical 234 
procedures in Menières disease. A recent study by Saliba et al. 2015 [20] compared endolymphatic 235 
sac decompression with endolymphatic duct blockage in a randomized non-blinded design. . This 236 
study compared two procedures related to the endolymphatic sac and was therefore not included in 237 
the present study. The study has an important risk of bias due to non-blinded design towards the 238 
patients and the observers, which might have biased the conclusions even though endolymphatic 239 
duct blockage was proven to be superior in vertigo control compared to endolymphatic sac 240 
decompression. Thus, it is important that the new surgical procedure of endolymphatic duct 241 
blockage is compared to a suspected non-effective placebo sham surgery in blinded design towards 242 
patients and observers conducting the clinical examinations.  243 
The well-known placebo effect in Menière’s disease, as well as the natural progression of this 244 
disease, serve as potentially serious confounders when seeking to evaluate treatment effects, and 245 
thus there is a need for large, well-performed RCT studies. We chose not to include non-246 
randomized trials in this review, because these types of studies would not sufficiently directly 247 
address our research question, in addition to the high risk of bias in these types of study designs. 248 
That being said, a review by Lim et al., (2015) [12], who included observational studies, also failed 249 
to substantiate the efficacy of this treatment in Menière’s disease and subsequently pointed towards 250 
the need for better research.  251 
As such, based on the current evidence, it is not possible to conclude whether endolymphatic 252 
surgery in Menière’s disease yields any positive results aside from a potential placebo effect. This is 253 
in line with the conclusions of other systematic reviews previously published on this matter [12,15]. 254 
Nevertheless, based on expert opinions, this treatment is still, in some cases, considered a good 255 
treatment option for Menière’s disease [11]. Given the fact that this is an invasive treatment, there is 256 
a high demand for well-performed studies that indeed show that the potential benefits following 257 
surgery exceeds the potential side effects.  258 
 259 
Strength and limitations of the current study 260 
This systematic review was performed using a transparent method and a priori defined criteria. This 261 
included a protocol registration, a systematic literature search, duplicate study selection, quality 262 
assessment, and data extraction. Limitations include a restricted search in study design and 263 
language. The results mentioned in this review are solely based upon the published data, as authors 264 
of the included studies were not contacted for further information.  265 
 266 
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 269 
Conclusion 270 
Given that endolymphatic sac surgery is an invasive procedure, there should be a demand for good 271 
evidence evaluating its potential beneficial effects and associated risks. However, until now there is 272 
still a lack of high quality research underlining the fact that endolymphatic sac surgery may provide 273 
significant and adequate symptomatic relief for patients diagnosed with Menière’s disease.  274 
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  331 
Figure legends 332 
 333 
Figure 1:  334 
Flowcharts showing the inclusion and exclusion of systematic reviews and primary studies 335 
 336 
Figure 2:  337 
Assessment of the methodological quality of the included systematic reviews (AMSTAR). The 338 
different domains are presented in the top row. The individual studies are shown in the left column.  339 
 340 
Figure 3:  341 
Risk of bias assessment as assessed by the Cochrane risk of bias tool. A plus (+) indicates low risk 342 
of bias; a question mark (?) indicates unclear risk of bias and a minus (-) indicates high risk of bias. 343 
The specific type of bias is presented in the top column, and the individual studies in the left row.  344 
 345 
